The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
Open accessAbstract
BACKGROUND: Although opioids are commonly used to treat chronic neuropathic pain, there are limited data to guide their use. Few controlled trials have been performed, and many types of neuropathic pain remain unstudied. METHODS: Adults with neuropathic pain that was refractory to treatment were randomly assigned to receive either high-strength (0.75-mg) or low-strength (0.15-mg) capsules of the potent mu-opioid agonist levorphanol for eight weeks under double-blind conditions. Intake was titrated by the patient to a maximum of 21 capsules of either strength per day. Outcome measures included the intensity of pain as recorded in a diary, the degree of pain relief, quality of life, psychological and cognitive function, the number of capsules taken daily, and blood levorphanol levels. RESULTS: Among the 81 patients exposed to the study drug, high-strength levorphanol capsules reduced pain by 36 percent, as compared with a 21 percent reduction in pain in the low-strength group (P=0.02). On average, patients in the high-strength group took 11.9 capsules per day (8.9 mg per day) and patients in the low-strength group took close to the 21 allowed (18.3 capsules per day; 2.7 mg per day). Affective distress and interference with functioning were reduced, and sleep was improved, but there were no differences between the high-strength group and the low-strength group in terms of these variables. Noncompletion of the study was primarily due to side effects of the opioid. Patients with central pain after stroke were the least likely to report benefit. CONCLUSIONS: The reduction in the intensity of neuropathic pain was significantly greater during treatment with higher doses of opioids than with lower doses. Higher doses produced more side effects without significant additional benefit in terms of other outcome measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The West Haven-Yale Multidimensional Pain Inventory (WHYMPI)
Kerns, R. D., Turk, D. C., & Rudy, T. E. (1985) · Pain · doi:10.1016/0304-3959(85)90004-1 · Cited by 2,128
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
Self-citationStructured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
Addiction Rare in Patients Treated with Narcotics
(1980) · New England Journal of Medicine · doi:10.1056/nejm198001103020221 · Cited by 1,106
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Arnér, S., & Meyerson, B. A. (1988) · Pain · doi:10.1016/0304-3959(88)90198-4 · Cited by 991
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
Max, M. B., Culnane, M., Schafer, S. C., Gracely, R. H., Walther, D. J., Smoller, B., & Dubner, R. (1987) · Neurology · doi:10.1212/wnl.37.4.589 · Cited by 702
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
Raja, S. N., Haythornthwaite, J. A., Pappagallo, M., Clark, M. R., Travison, T. G., Sabeen, S., Royall, R. M., & Max, M. B. (2002) · Neurology · doi:10.1212/wnl.59.7.1015 · Cited by 593
Portenoy, R. K., Foley, K. M., & Inturrisi, C. E. (1990) · Pain · doi:10.1016/0304-3959(90)90025-9 · Cited by 565
Cited by
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Dworkin, R. H., Backonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C. R., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., Haythornthwaite, J. A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1524 · Cited by 1,216
Self-citationThe evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy
Van Zee, A. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.131714 · Cited by 910
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Central post-stroke pain: clinical characteristics, pathophysiology, and management
Klit, H., Finnerup, N. B., & Jensen, T. S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70176-0 · Cited by 672
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Self-citationMu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations
Chu, L. F., Angst, M. S., & Clark, D. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f43 · Cited by 575
Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00370.x · Cited by 565
Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N. M., Shilliday, B. B., DeWalt, D. A., & Pignone, M. P. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-46 · Cited by 519
O'Connor (2009) · doi:10.2165/00019053-200927020-00002 · Cited by 438
McNicol, E. D., Midbari, A., & Eisenberg, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006146.pub2 · Cited by 434
Eisenberg, E., McNicol, E. D., & Carr, D. B. (2005) · JAMA · doi:10.1001/jama.293.24.3043 · Cited by 407
A Comprehensive Algorithm for Management of Neuropathic Pain
Bates, D., Schultheis, B. C., Hanes, M. C., Jolly, S. M., Chakravarthy, K. V., Deer, T. R., Levy, R. M., & Hunter, C. W. (2019) · Pain Medicine · doi:10.1093/pm/pnz075 · Cited by 401
Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review
Hempenstall, K., Nurmikko, T. J., Johnson, R. W., A'Hern, R. P., & Rice, A. S. C. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020164 · Cited by 400
Complex regional pain syndrome
Birklein, F. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0737-8 · Cited by 394
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., Baron, R., Bellamy, N., Burke, L. B., Chappell, A., Chartier, K., Cleeland, C. S., Costello, A., et al. (2010) · Pain · doi:10.1016/j.pain.2010.02.018 · Cited by 381
Cell Signaling and the Genesis of Neuropathic Pain
Ji, R.-R., & Strichartz, G. (2004) · Science's STKE · doi:10.1126/stke.2522004re14 · Cited by 371
Efficacy of Opioids for Chronic Pain: A Review of the Evidence
Ballantyne, J. C., & Shin, N. S. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f26 · Cited by 360
Shoulder Pain After Stroke: A Prospective Population-Based Study
Lindgren, I., Jönsson, A.-C., Norrving, B., & Lindgren, A. (2007) · Stroke · doi:10.1161/01.str.0000254598.16739.4e · Cited by 304
Opioid Guidelines in the Management of Chronic Non-Cancer Pain
Manchikanti, L. (2006) · Pain Physician · doi:10.36076/ppj.2006/9/2 · Cited by 277
Mendell, J. R., & Sahenk, Z. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp022282 · Cited by 270
Serpell, M., Ratcliffe, S., Hovorka, J., Schofield, M., Taylor, L., Lauder, H., & Ehler, E. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00445.x · Cited by 197
Lim, G., Sung, B., Ji, R.-R., & Mao, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00242-2 · Cited by 195
“…(NMDAR) antagonists, local anesthetics, anti-epileptic drugs, and opioid analgesics (Watson and Evans, 1982; Watson et al., 1982; Kishore-Kumar et al., 1990; Max et al., 1991, 1992, 1994; Kingery, 1997; Sindrup and Jensen, 1999; Mao and Chen, 2000a,b; Raja et al., 2002; Rowbotham et al., 2003).”
BackgroundWalczak, J.-S., Pichette, V., Leblond, F., Desbiens, K., & Beaulieu, P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.010 · Cited by 133
Management of Chronic Pain in Cancer Survivors
Levy, M. H., Chwistek, M., & Mehta, R. S. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31818f5aa7 · Cited by 125
Walczak, J., Pichette, V., Leblond, F., Desbiens, K., & Beaulieu, P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20821 · Cited by 62
(2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00012-2 · Cited by 51
Rajguru, P., Kolber, M. J., Garcia, A. N., Smith, M. T., Patel, C. K., & Hanney, W. J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614522580 · Cited by 18
Metadata
- Authors
- Rowbotham, M. C., Twilling, L., Davies, P. S., Reisner, L., Taylor, K., & Mohr, D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-03-27
- Volume
- 348
- Issue
- 13
- Pages
- 1223-1232
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1964575045
- Cited by
- 529
- References
- 28
- FWCI
- 50.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.